Tag: Pharma company
Oramed provides doses to patients across multiple sites
Oramed Pharmaceuticals Inc has announced that randomization of patients in its first Phase 3 study of its oral insulin capsule ORMD-0801 for the treatment...
Biohaven gives important update on phase 2/3 trial and Alzheimer’s disease...
Biohaven Pharmaceutical Holding Company Ltd has announced completed a focused analysis of the topline co-primary and key secondary data from its Phase 2/3 clinical...